Loxapine in patient with clozapine-resistant psychosis.

antipsychotic agents clozapine loxapine schizophrenia

Journal

The mental health clinician
ISSN: 2168-9709
Titre abrégé: Ment Health Clin
Pays: United States
ID NLM: 101728585

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 25 09 2020
accepted: 21 04 2021
entrez: 28 7 2021
pubmed: 29 7 2021
medline: 29 7 2021
Statut: epublish

Résumé

Clozapine is recognized as the drug of choice for treatment-refractory schizophrenia, but use may be limited because of strict monitoring requirements and adverse effects including severe neutropenia, seizures, and myocarditis. Loxapine is a first-generation antipsychotic with similarities to clozapine in both structure and receptor binding. This case describes a 57-year-old male with a history of severe paranoid schizophrenia despite treatment with clozapine and other psychotropic agents, who experienced clinical improvement after a cross titration from clozapine to loxapine. Loxapine may be a reasonable alternative in patients with treatment-refractory schizophrenia who do not tolerate or respond to clozapine.

Identifiants

pubmed: 34316424
doi: 10.9740/mhc.2021.07.263
pii: MHC-D-20-00078
pmc: PMC8287867
doi:

Types de publication

Case Reports

Langues

eng

Pagination

263-266

Informations de copyright

© 2021 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists.

Déclaration de conflit d'intérêts

Disclosures: The authors have no conflicts of interest to disclose.

Références

Ann Gen Psychiatry. 2015 Apr 01;14:15
pubmed: 25859275
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001943
pubmed: 17943763
Case Rep Psychiatry. 2016;2016:6123913
pubmed: 27433365
J Psychiatry Neurosci. 2003 Jan;28(1):39-47
pubmed: 12587849
Am J Psychiatry. 2020 Sep 1;177(9):868-872
pubmed: 32867516
Ther Clin Risk Manag. 2017 Jun 29;13:757-777
pubmed: 28721057
Eur J Clin Pharmacol. 2012 Jun;68(6):951-60
pubmed: 22258279
Arch Gen Psychiatry. 1988 Sep;45(9):789-96
pubmed: 3046553
Ann Clin Psychiatry. 1996 Dec;8(4):193-7
pubmed: 8986313
Clin Pharmacokinet. 2003;42(7):607-18
pubmed: 12844323

Auteurs

Jennifer Erley (J)

Psychiatry Pharmacy Resident, Michigan Medicine & University of Michigan College of Pharmacy, Ann Arbor, Michigan.
Psychiatry Pharmacy Specialist, Michigan Medicine & University of Michigan College of Pharmacy, Ann Arbor, Michigan.
Psychiatry Resident, Michigan Medicine, Ann Arbor, Michigan.

Sarah Goldsborough (S)

Psychiatry Pharmacy Resident, Michigan Medicine & University of Michigan College of Pharmacy, Ann Arbor, Michigan.

Amy VandenBerg (A)

Psychiatry Pharmacy Specialist, Michigan Medicine & University of Michigan College of Pharmacy, Ann Arbor, Michigan.

Alexandra Audu (A)

Psychiatry Resident, Michigan Medicine, Ann Arbor, Michigan.

Classifications MeSH